Mucosolvan prevent inhalation of respiratory complications after thoracotomy Efficacy.doc
- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Mucosolvan prevent inhalation of respiratory complications after thoracotomy Efficacy
PAGE \* MERGEFORMAT 7
Mucosolvan prevent inhalation of respiratory complications after thoracotomy Efficacy
[Abstract] Ambroxol preoperative inhalation of oxygen-driven help reduce the incidence of respiratory complications after thoracotomy.
[Keywords:] Mucosolvan oxygen inhalation respiratory complications after thoracotomy In this study, preoperative inhalation of ambroxol and simple method of oxygen inhalation were compared to observe the preventive effect of respiratory complications after thoracotomy and effect.
1 Data and methods 1.1 The object of study selected in January 2008 -2008 in December at the undergraduate line treatment of patients with 80 patients undergoing thoracic surgery. Randomly divided into two groups and the control group. Observation group 24 males and 16 females, aged 35-78 years (60.92 old + -9.75 years. at the 1987 International UICC criteria, including 6 cases of lung cancer, esophageal cancer in 25 cases, cardiac in 9 patients. control group, 23 males and 17 females, aged 44-79 years (62.75 + -8.78 years old . including 8 cases of lung cancer, 21 cases of esophageal cancer, gastric cardia in 11 cases. Both groups were age, sex and disease were no significant differences (Pgt; 0.05), comparable. into the choice: patients aged 18 to 80 years , no other similar expectorant drug used, can be self-conscious expectoration. exclusion criteria: ambroxol on allergies, liver and kidney dysfunction in patients who can not cope with mental state.
Study medication and equipment 1.2
Boehringer Corporation needle Ambroxol 15mg/2ml, oxygen inhalation device.
1.3 Methods 1.3.1 administration to observe the group: 2-3 days before surgery with Ambroxol 15mg 20ml normal saline inhalation of oxygen-driven, oxygen flow 6-8L/min, 2 times a day, every 15-20min. After Ambroxol 30mg given intravenously 2 times a day for 7 days. control group received saline before routine oxygen inhalation, the method with the observa
您可能关注的文档
- Mount acquisition of Chongqing to help-.doc
- Motorola Iridium the failure of the business model-.doc
- Mount four-leaf polysaccharide on young mice and the immune regulation of the immune mice.doc
- Mount Industry Nirvana.doc
- Mou-moving moving the speed - Hisense brand management and promotional strategies Analysis.doc
- Motorola unworthy 'IT Whampoa' title!.doc
- Mount providers how to make promotional not a 'tasteless'.doc
- Mou Qizhong- Mood 'sunny days than there are clouds'.doc
- Mount show will die-.doc
- Motorola- Technology paranoia of the crises and difficulties.doc
文档评论(0)